Sharma East India Hosp and Medical Research Ltd.
|BSE: 524548||Sector: Health care|
|NSE: N.A.||ISIN Code: INE465H01012|
|BSE 05:30 | 01 Jan||Sharma East India Hosp and Medical Research Ltd|
|NSE 05:30 | 01 Jan||Sharma East India Hosp and Medical Research Ltd|
Sharma East India Hosp and Medical Research Ltd. (SHARMAEIHOSP) - News Sector
1.20 pm | 30 Oct 2020 | Bloomberg
The pharmaceutical sector is the top performer in India's $2.1 trillion equity market this year after the coronavirus pandemic turned global investors...
12.20 pm | 30 Oct 2020 | Business Standard
Mahindra & Mahindra, Page Industries, TVS Motor Company, and Wockhardt are among the noticeable names that are exhibiting trend reversal.
9.41 am | 30 Oct 2020 | Business Standard
The company's Ebitda margins improved 1,349 basis points to 32.8 per cent due to better product mix and improved operating leverage
7.50 pm | 29 Oct 2020 | Business Standard
In talks with global players seeking manufacturing opportunity for potential Covid-19 vaccine
4.32 pm | 29 Oct 2020 | Business Standard
This will help take stroke management to the next level by standardising diagnosis and empowering clinicians to make faster, more accurate diagnoses a...
1.00 pm | 29 Oct 2020 | Business Standard
Keki Dadiseth, Dr. R.A. Mashelkar and Prof. Goverdhan Mehta, independent directors on the board of Piramal Enterprises have resigned, the company info...
12.35 pm | 29 Oct 2020 | Business Standard
In the past six months, Ajanta Pharma has underperformed the market by gaining 8.9 per cent against 26 per cent rally in S&P BSE Healthcare index
12.43 am | 29 Oct 2020 | Business Standard
Wockhardt buy, Covid portfolio aid India business growth
12.05 am | 29 Oct 2020 | Business Standard
Sputnik V is also undergoing Phase 3 clinical trials in Russia and other parts of the globe on 40,000 volunteers
12.25 pm | 28 Oct 2020 | Business Standard
Ipca Labs has tripled in the last one year from the lows of Rs 817 and continues to hold the same strength and momentum. Charts indicate more headroom...
12.19 am | 28 Oct 2020 | Business Standard
Chronic and sub-chronic therapies, accounting for 77 per cent of India sales, are outperforming the domestic market, say analysts
4.06 pm | 27 Oct 2020 | Business Standard
All that happened in the markets today
12.17 pm | 27 Oct 2020 | Business Standard
Shriram Transport Finance, Asian Paints, Nestle India, L&T, Bajaj Finance, Colgate-Palmolive India, Shree Cement, Ipca Laboratories, NTPC and Pidilite...
10.55 am | 27 Oct 2020 | Business Standard
In Q2FY21, the company's Ebitda margins are likely to improve 740 basis points YoY to 28 per cent
8.51 am | 27 Oct 2020 | Business Standard
Here's a list of stocks that may trade actively in today's session.
1.46 am | 27 Oct 2020 | Business Standard
Aurobindo's stock reacted positively to the news, going up in morning trade but later settled flat at Rs 784.65 on the BSE
10.20 pm | 26 Oct 2020 | Business Standard
Company to also launch a digital solution for all healthcare needs and plans to rope in partners
7.32 pm | 26 Oct 2020 | Business Standard
Firm's consolidated total revenue for the quarter, however, fell marginally by 0.7% to stand at Rs 2,023 crore
2.58 pm | 26 Oct 2020 | Business Standard
The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses
12.06 pm | 26 Oct 2020 | Business Standard
Earlier this month, the company reported nearly 37 per cent year-on-year and over 100 per cent sequential growth in aggregate revenue for Q2FY21